138 related articles for article (PubMed ID: 26466942)
1. Protein Kinase CK2 Content in GL261 Mouse Glioblastoma.
Ferrer-Font L; Alcaraz E; Plana M; Candiota AP; Itarte E; Arús C
Pathol Oncol Res; 2016 Jul; 22(3):633-7. PubMed ID: 26466942
[TBL] [Abstract][Full Text] [Related]
2. Up-Regulation of the Alpha Prime Subunit of Protein Kinase CK2 as a Marker of Fast Proliferation in GL261 Cultured Cells.
Villamañan L; Alcaraz E; Pinna LA; Ruzzene M; Itarte E; Arús C; Plana M; Candiota AP
Pathol Oncol Res; 2019 Oct; 25(4):1659-1663. PubMed ID: 30607803
[TBL] [Abstract][Full Text] [Related]
3. Casein kinase 2α regulates glioblastoma brain tumor-initiating cell growth through the β-catenin pathway.
Nitta RT; Gholamin S; Feroze AH; Agarwal M; Cheshier SH; Mitra SS; Li G
Oncogene; 2015 Jul; 34(28):3688-99. PubMed ID: 25241897
[TBL] [Abstract][Full Text] [Related]
4. Targeting Protein Kinase CK2: Evaluating CX-4945 Potential for GL261 Glioblastoma Therapy in Immunocompetent Mice.
Ferrer-Font L; Villamañan L; Arias-Ramos N; Vilardell J; Plana M; Ruzzene M; Pinna LA; Itarte E; Arús C; Candiota AP
Pharmaceuticals (Basel); 2017 Feb; 10(1):. PubMed ID: 28208677
[TBL] [Abstract][Full Text] [Related]
5. Protein kinase CK2 is important for the function of glioblastoma brain tumor initiating cells.
Rowse AL; Gibson SA; Meares GP; Rajbhandari R; Nozell SE; Dees KJ; Hjelmeland AB; McFarland BC; Benveniste EN
J Neurooncol; 2017 Apr; 132(2):219-229. PubMed ID: 28181105
[TBL] [Abstract][Full Text] [Related]
6. Metronomic treatment in immunocompetent preclinical GL261 glioblastoma: effects of cyclophosphamide and temozolomide.
Ferrer-Font L; Arias-Ramos N; Lope-Piedrafita S; Julià-Sapé M; Pumarola M; Arús C; Candiota AP
NMR Biomed; 2017 Sep; 30(9):. PubMed ID: 28570014
[TBL] [Abstract][Full Text] [Related]
7. Novel small molecule protein kinase CK2 inhibitors exert potent antitumor effects on T98G and SEGA cells in vitro.
Pucko E; Ostrowski R; Matyja E
Folia Neuropathol; 2019; 57(3):239-248. PubMed ID: 31588710
[TBL] [Abstract][Full Text] [Related]
8. Targeting protein kinase CK2 suppresses prosurvival signaling pathways and growth of glioblastoma.
Zheng Y; McFarland BC; Drygin D; Yu H; Bellis SL; Kim H; Bredel M; Benveniste EN
Clin Cancer Res; 2013 Dec; 19(23):6484-94. PubMed ID: 24036851
[TBL] [Abstract][Full Text] [Related]
9. Differential localization of alpha' and beta subunits of protein kinase CK2 during rat spermatogenesis.
Alvarado-Díaz CP; Tapia JC; Antonelli M; Moreno RD
Cell Tissue Res; 2009 Oct; 338(1):139-49. PubMed ID: 19711102
[TBL] [Abstract][Full Text] [Related]
10. Toward selective CK2alpha and CK2alpha' inhibitors: Development of a novel whole-cell kinase assay by Autodisplay of catalytic CK2alpha'.
Bollacke A; Nienberg C; Borgne ML; Jose J
J Pharm Biomed Anal; 2016 Mar; 121():253-260. PubMed ID: 26786382
[TBL] [Abstract][Full Text] [Related]
11. SYK inhibition blocks proliferation and migration of glioma cells and modifies the tumor microenvironment.
Moncayo G; Grzmil M; Smirnova T; Zmarz P; Huber RM; Hynx D; Kohler H; Wang Y; Hotz HR; Hynes NE; Keller G; Frank S; Merlo A; Hemmings BA
Neuro Oncol; 2018 Apr; 20(5):621-631. PubMed ID: 29401256
[TBL] [Abstract][Full Text] [Related]
12. Protein kinase CK2: evidence for a protein kinase CK2beta subunit fraction, devoid of the catalytic CK2alpha subunit, in mouse brain and testicles.
Guerra B; Siemer S; Boldyreff B; Issinger OG
FEBS Lett; 1999 Dec; 462(3):353-7. PubMed ID: 10622724
[TBL] [Abstract][Full Text] [Related]
13. CK2 inhibition induced PDK4-AMPK axis regulates metabolic adaptation and survival responses in glioma.
Dixit D; Ahmad F; Ghildiyal R; Joshi SD; Sen E
Exp Cell Res; 2016 May; 344(1):132-142. PubMed ID: 27001465
[TBL] [Abstract][Full Text] [Related]
14. The activity of CK2 in the extracts of COS-7 cells transfected with wild type and mutant subunits of protein kinase CK2.
Korn I; Jacob G; Allende CC; Allende JE
Mol Cell Biochem; 2001 Nov; 227(1-2):37-44. PubMed ID: 11827173
[TBL] [Abstract][Full Text] [Related]
15. Identification of a Druggable Pathway Controlling Glioblastoma Invasiveness.
Pencheva N; de Gooijer MC; Vis DJ; Wessels LFA; Würdinger T; van Tellingen O; Bernards R
Cell Rep; 2017 Jul; 20(1):48-60. PubMed ID: 28683323
[TBL] [Abstract][Full Text] [Related]
16. Different expression patterns of CK2 subunits in the brains of experimental animals and patients with transmissible spongiform encephalopathies.
Chen JM; Gao C; Shi Q; Shan B; Lei YJ; Dong CF; An R; Wang GR; Zhang BY; Han J; Dong XP
Arch Virol; 2008; 153(6):1013-20. PubMed ID: 18404245
[TBL] [Abstract][Full Text] [Related]
17. Inducible expression of the regulatory protein kinase CK2beta subunit: incorporation into complexes with catalytic CK2 subunits and re-examination of the effects of CK2beta on cell proliferation.
Vilk G; Derksen DR; Litchfield DW
J Cell Biochem; 2001; 84(1):84-99. PubMed ID: 11746518
[TBL] [Abstract][Full Text] [Related]
18. Reduced phosphorylation of Stat3 at Ser-727 mediated by casein kinase 2 - protein phosphatase 2A enhances Stat3 Tyr-705 induced tumorigenic potential of glioma cells.
Mandal T; Bhowmik A; Chatterjee A; Chatterjee U; Chatterjee S; Ghosh MK
Cell Signal; 2014 Aug; 26(8):1725-34. PubMed ID: 24726840
[TBL] [Abstract][Full Text] [Related]
19. Dimethyl sulfoxide (DMSO) as a potential contrast agent for brain tumors.
Delgado-Goñi T; Martín-Sitjar J; Simões RV; Acosta M; Lope-Piedrafita S; Arús C
NMR Biomed; 2013 Feb; 26(2):173-84. PubMed ID: 22814967
[TBL] [Abstract][Full Text] [Related]
20. Structure of the human protein kinase CK2 catalytic subunit CK2α' and interaction thermodynamics with the regulatory subunit CK2β.
Bischoff N; Olsen B; Raaf J; Bretner M; Issinger OG; Niefind K
J Mol Biol; 2011 Mar; 407(1):1-12. PubMed ID: 21241709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]